Clinical Trial Update: Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing continuous versus intermittent administration of ceftazidime and analyzing its pharmacokinetics in cerebrospinal fluid for patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Meningitis

Drugs mentioned

• ceftazidime (ceftazidime)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Pseudomonas Aeruginosa Meningitis | Phase 2 | Status: UNKNOWN